• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌硬化性骨转移的组织形态计量学分析——特别提及骨软化症

Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia.

作者信息

Charhon S A, Chapuy M C, Delvin E E, Valentin-Opran A, Edouard C M, Meunier P J

出版信息

Cancer. 1983 Mar 1;51(5):918-24. doi: 10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j.

DOI:10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j
PMID:6681595
Abstract

Transiliac undecalcified bone biopsy specimens were taken after tetracycline double labeling from 14 patients with radiologic evidence of osteosclerotic metastases from prostatic carcinoma. The histomorphometric analysis showed an increased trabecular bone volume in all patients, and in seven morphologic and dynamic evidence of osteomalacia (Group 1). The seven other patients demonstrated an extension of apposition surfaces without evidence of osteomalacia (Group 2). Group 1 was different from Group 2 in terms of a greater increase in serum alkaline phosphatase and a lower urinary calcium. In four Group 1 patients, a second bone sample taken after two to six months of treatment with vitamin D and calcium provided evidence of improving osteomalacia. The high incidence of osteomalacia in osteosclerotic metastases of prostatic origin appears to be the result of the increase in bone formation induced by prostatic cells, and the unability to satisfy the high calcium demand for new bone.

摘要

在四环素双重标记后,从14例有前列腺癌骨硬化转移放射学证据的患者身上获取经髂骨未脱钙骨活检标本。组织形态计量学分析显示,所有患者的小梁骨体积均增加,其中7例有骨软化的形态学和动力学证据(第1组)。其他7例患者显示骨表面沉积增加,但无骨软化证据(第2组)。第1组与第2组的不同之处在于血清碱性磷酸酶升高幅度更大,尿钙水平更低。在4例第1组患者中,在接受维生素D和钙治疗2至6个月后采集的第二份骨样本显示骨软化有所改善。前列腺来源的骨硬化转移中骨软化的高发生率似乎是前列腺细胞诱导的骨形成增加以及无法满足新骨形成对高钙需求的结果。

相似文献

1
Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia.前列腺癌硬化性骨转移的组织形态计量学分析——特别提及骨软化症
Cancer. 1983 Mar 1;51(5):918-24. doi: 10.1002/1097-0142(19830301)51:5<918::aid-cncr2820510526>3.0.co;2-j.
2
Osteoblast function and osteomalacia in metastatic prostate cancer.转移性前列腺癌中的成骨细胞功能与骨软化症
Eur Urol. 1993;24(2):286-90. doi: 10.1159/000474311.
3
[Prostatic osteocondensing metastases and osteomalacia. Value of histomorphometric study. Preliminary results].[前列腺骨凝聚性转移与骨软化症。组织形态计量学研究的价值。初步结果]
Presse Med. 1985 Oct 19;14(35):1823-7.
4
Osteomalacia and carcinoma of prostate with major redistribution of skeletal calcium.骨软化症与前列腺癌伴骨骼钙的主要重新分布。
Br J Radiol. 1975 Jun;48(570):451-6. doi: 10.1259/0007-1285-48-570-451.
5
[Vitamin-sensitive osteomalacia in condensing bone metastases of prostatic origin. Apropos of 2 cases].
Rev Rhum Mal Osteoartic. 1981 Jun;48(6):469-76.
6
[Prostatic osteocondensing metastases. The value of examining for osteomalacia].[前列腺骨凝聚性转移。检查骨软化症的价值]
Ann Urol (Paris). 1985;19(3):203-6.
7
Sclerotic bone metastases of prostatic origin and osteomalacia. Importance of a histomorphometry study.
Prog Clin Biol Res. 1987;243A:569-71.
8
Osteomalacia associated with prostatic cancer and osteoblastic metastases.与前列腺癌和成骨细胞转移相关的骨软化症
Urology. 1983 Jan;21(1):65-7. doi: 10.1016/0090-4295(83)90129-2.
9
Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication.铝中毒患者中骨形成率低,无论有无骨软化的组织学表现。
J Lab Clin Med. 1985 Aug;106(2):123-31.
10
Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry.胃切除术后的骨质减少和骨软化症:骨重塑生化标志物、维生素D代谢产物与骨组织形态计量学之间的相互关系
Gut. 1991 Nov;32(11):1303-7. doi: 10.1136/gut.32.11.1303.

引用本文的文献

1
Acute Management of Hypercalcemia of Malignancy - A Review of Pathophysiology, Diagnosis, and Treatment.恶性肿瘤高钙血症的急性处理——病理生理学、诊断与治疗综述
Curr Oncol Rep. 2025 May 28. doi: 10.1007/s11912-025-01685-z.
2
Radium-223 Treatment Produces Prolonged Suppression of Resident Osteoblasts and Decreased Bone Mineral Density in Trabecular Bone in Osteoblast Reporter Mice.镭-223治疗可使成骨细胞报告基因小鼠的驻留成骨细胞长期受抑制,并使小梁骨的骨矿物质密度降低。
Cancers (Basel). 2024 Jul 21;16(14):2603. doi: 10.3390/cancers16142603.
3
Prostate cancer and bone: clinical presentation and molecular mechanisms.
前列腺癌与骨骼:临床表现与分子机制。
Endocr Relat Cancer. 2023 Jul 25;30(9). doi: 10.1530/ERC-22-0360. Print 2023 Sep 1.
4
Bibliometric analysis of the global research development of bone metastases in prostate cancer: A 22-year study.前列腺癌骨转移全球研究发展的文献计量分析:一项为期22年的研究。
Front Oncol. 2022 Sep 27;12:947445. doi: 10.3389/fonc.2022.947445. eCollection 2022.
5
A Method of Bone-Metastatic Tumor Progression Assessment in Mice Using Longitudinal Radiography.一种利用纵向X线摄影术评估小鼠骨转移性肿瘤进展的方法。
Methods Mol Biol. 2022;2413:1-6. doi: 10.1007/978-1-0716-1896-7_1.
6
Prostate Cancer Cell Extracellular Vesicles Increase Mineralisation of Bone Osteoblast Precursor Cells in an In Vitro Model.在体外模型中,前列腺癌细胞外囊泡可增加骨成骨细胞前体细胞的矿化作用。
Biology (Basel). 2021 Apr 10;10(4):318. doi: 10.3390/biology10040318.
7
Printing the Pathway Forward in Bone Metastatic Cancer Research: Applications of 3D Engineered Models and Bioprinted Scaffolds to Recapitulate the Bone-Tumor Niche.描绘骨转移性癌症研究的前进道路:3D工程模型和生物打印支架在重现骨肿瘤微环境中的应用
Cancers (Basel). 2021 Jan 29;13(3):507. doi: 10.3390/cancers13030507.
8
Regulation of Osteosclerosis by Inoculated Cd133 PC3 Cells in Bone-marrow Microenvironmental Niches.接种的Cd133阳性PC3细胞在骨髓微环境龛中对骨硬化的调节作用
JBMR Plus. 2019 May 20;3(7):e10189. doi: 10.1002/jbm4.10189. eCollection 2019 Jul.
9
The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases.骨细胞外基质作为癌细胞转移的理想环境。
Cancers (Basel). 2019 Jul 20;11(7):1020. doi: 10.3390/cancers11071020.
10
Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.癌症转移至骨:概念、机制以及与骨成骨细胞的相互作用
Cancers (Basel). 2018 Jun 4;10(6):182. doi: 10.3390/cancers10060182.